https://orcid.org/0000-0003-2123-9603
Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Karim Mahnam & Seyed Mehdi Rajaee. (2023) A theoretical survey to find potential natural compound for inhibition of binding the RBD domain to ACE2 receptor based on plant antivirals. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-26.
Read now
Read now
Dongning Li, Jie Zhang & Xiaoyan Zhao. (2021) Mechanisms and Molecular Targets of Artemisinin in Cancer Treatment. Cancer Investigation 39:8, pages 675-684.
Read now
Read now
Articles from other publishers (26)
Yingchao Shi, Wenhao Liu, Yang Yang, Yali Ci & Lei Shi. (2023) Exploration of the Shared Molecular Mechanisms between COVID-19 and Neurodegenerative Diseases through Bioinformatic Analysis. International Journal of Molecular Sciences 24:5, pages 4839.
Crossref
Crossref
Joshua Iseoluwa Orege, Sherif Babatunde Adeyemi, Bashir Bolaji Tiamiyu, Toluwanimi Oluwadara Akinyemi, Yusuf Ajibola Ibrahim & Odunola Blessing Orege. (2021) Artemisia and Artemisia-based products for COVID-19 management: current state and future perspective. Advances in Traditional Medicine 23:1, pages 85-96.
Crossref
Crossref
Ibrahim Jantan, Laiba Arshad, Abdi Wira Septama, Md. Areeful Haque, Zeti‐Azura Mohamed‐Hussein & Nisha T. Govender. (2022) Antiviral effects of phytochemicals against severe acute respiratory syndrome coronavirus 2 and their mechanisms of action: A review. Phytotherapy Research 37:3, pages 1036-1056.
Crossref
Crossref
Nosheen Malak, Sadaf Niaz, Nasreen Nasreen, Adil Khan & Sara Sarfaraz. 2023. Application of Natural Products in SARS-CoV-2. Application of Natural Products in SARS-CoV-2
143
170
.
Ananya Chugh, Ishita Sehgal, Nimisha Khurana, Kangna Verma, Rajan Rolta, Pranjal Vats, Deeksha Salaria, Olatomide A. Fadare, Oladoja Awofisayo, Anita Verma, Rajendra Phartyal & Mansi Verma. (2023) Comparative docking studies of drugs and phytocompounds for emerging variants of SARS-CoV-2. 3 Biotech 13:1.
Crossref
Crossref
Ángela del Castillo-Izquierdo, José María Moreno-Navarrete, Jessica Latorre, María Arnoriaga-Rodríguez, Marta Ballanti, Giovanni Monteleone, Omero Alessandro Paoluzi, Geltrude Mingrone, Josep Puig, Rafael Ramos, Josep Garre-Olmo, Mariona Jové, Reinald Pamplona, Manuel Portero-Otín, Joaquim Sol, Philippe Lefebvre, Bart Staels, Massimo Federici, José Manuel Fernández-Real & Jordi Mayneris-Perxachs. (2022) DPP9 as a Potential Novel Mediator in Gastrointestinal Virus Infection. Antioxidants 11:11, pages 2177.
Crossref
Crossref
Yongqun He, Hong Yu, Anthony Huffman, Asiyah Yu Lin, Darren A. Natale, John Beverley, Ling Zheng, Yehoshua Perl, Zhigang Wang, Yingtong Liu, Edison Ong, Yang Wang, Philip Huang, Long Tran, Jinyang Du, Zalan Shah, Easheta Shah, Roshan Desai, Hsin-hui Huang, Yujia Tian, Eric Merrell, William D. Duncan, Sivaram Arabandi, Lynn M. Schriml, Jie Zheng, Anna Maria Masci, Liwei Wang, Hongfang Liu, Fatima Zohra Smaili, Robert Hoehndorf, Zoë May Pendlington, Paola Roncaglia, Xianwei Ye, Jiangan Xie, Yi-Wei Tang, Xiaolin Yang, Suyuan Peng, Luxia Zhang, Luonan Chen, Junguk Hur, Gilbert S. Omenn, Brian Athey & Barry Smith. (2022) A comprehensive update on CIDO: the community-based coronavirus infectious disease ontology. Journal of Biomedical Semantics 13:1.
Crossref
Crossref
Vino Palani, Santhosh Chinnaraj, Murugesh Shanmugasundaram, Arunkumar Malaisamy, Viji Maluventhen, Vijaya Anand Arumugam, Kannan R. R. Rengasamy, Balamuralikrishnan Balasubramanian, Wen-Chao Liu & Maruthupandian Arumugam. (2022) Derivation, Functionalization of (S)-Goniothalamin from Goniothalamus wightii and Their Derivative Targets SARS-CoV-2 MPro, SPro, and RdRp: A Pharmacological Perspective. Molecules 27:20, pages 6962.
Crossref
Crossref
Gelareh Abdolmaleki, Mina Azam Taheri, Sarina Paridehpour, Neshaut Mashreghi Mohammadi, Yasaman Ahmadi Tabatabaei, Taraneh Mousavi & Mohsen Amin. (2022) A comparison between SARS-CoV-1 and SARS-CoV2: an update on current COVID-19 vaccines. DARU Journal of Pharmaceutical Sciences 30:2, pages 379-406.
Crossref
Crossref
Jingyuan Zhang, Yun Li, Jingxuan Wan, Mengyuan Zhang, Chunxiao Li & Jiangtao Lin. (2022) Artesunate: A review of its therapeutic insights in respiratory diseases. Phytomedicine 104, pages 154259.
Crossref
Crossref
Laure-Alix Clerbaux, Maria Cristina Albertini, Núria Amigó, Anna Beronius, Gillina F. G. Bezemer, Sandra Coecke, Evangelos P. Daskalopoulos, Giusy del Giudice, Dario Greco, Lucia Grenga, Alberto Mantovani, Amalia Muñoz, Elma Omeragic, Nikolaos Parissis, Mauro Petrillo, Laura A. Saarimäki, Helena Soares, Kristie Sullivan & Brigitte Landesmann. (2022) Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework. Journal of Clinical Medicine 11:15, pages 4464.
Crossref
Crossref
Estefanía Calvo-Alvarez, Maria Dolci, Federica Perego, Lucia Signorini, Silvia Parapini, Sarah D’Alessandro, Luca Denti, Nicoletta Basilico, Donatella Taramelli, Pasquale Ferrante & Serena Delbue. (2022) Antiparasitic Drugs against SARS-CoV-2: A Comprehensive Literature Survey. Microorganisms 10:7, pages 1284.
Crossref
Crossref
Pawan K. Agrawal, Chandan Agrawal & Gerald Blunden. (2022) Artemisia Extracts and Artemisinin-Based Antimalarials for COVID-19 Management: Could These Be Effective Antivirals for COVID-19 Treatment?. Molecules 27:12, pages 3828.
Crossref
Crossref
Karim Farmanpour-Kalalagh, Arman Beyraghdar Kashkooli, Alireza Babaei, Ali Rezaei & Alexander R. van der Krol. (2022) Artemisinins in Combating Viral Infections Like SARS-CoV-2, Inflammation and Cancers and Options to Meet Increased Global Demand. Frontiers in Plant Science 13.
Crossref
Crossref
Riadh Badraoui, Mongi Saoudi, Walid S. Hamadou, Salem Elkahoui, Arif J. Siddiqui, Jahoor M. Alam, Arshad Jamal, Mohd Adnan, Abdel M. E. Suliemen, Mousa M. Alreshidi, Dharmendra K. Yadav, Houcine Naïli & Hmed Ben-Nasr. (2022) Antiviral Effects of Artemisinin and Its Derivatives against SARS-CoV-2 Main Protease: Computational Evidences and Interactions with ACE2 Allelic Variants. Pharmaceuticals 15:2, pages 129.
Crossref
Crossref
Takuro Endo, Hitoshi Takemae, Indu Sharma & Tetsuya Furuya. (2021) Multipurpose Drugs Active Against Both Plasmodium spp. and Microorganisms: Potential Application for New Drug Development. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Prem Kumar, Jeladhara Sobhanan, Yuta Takano & Vasudevanpillai Biju. (2021) Molecular recognition in the infection, replication, and transmission of COVID-19-causing SARS-CoV-2: an emerging interface of infectious disease, biological chemistry, and nanoscience. NPG Asia Materials 13:1.
Crossref
Crossref
Fei Chen, Yankun Zhang, Xiaoyun Li, Wen Li, Xuan Liu & Xinyu Xue. (2021) The Impact of ACE2 Polymorphisms on COVID-19 Disease: Susceptibility, Severity, and Therapy. Frontiers in Cellular and Infection Microbiology 11.
Crossref
Crossref
Saholinirina Randrianarivo, Claudine Rasolohery, Sitraka Rafanomezantsoa, Heriniaina Randriamampionona, Liti Haramaty, Roger Marie Rafanomezantsoa & Eric H. Andrianasolo. (2021) (−)-6-epi-Artemisinin, a Natural Stereoisomer of (+)-Artemisinin in the Opposite Enantiomeric Series, from the Endemic Madagascar Plant Saldinia proboscidea, an Atypical Source. Molecules 26:18, pages 5540.
Crossref
Crossref
Dires Tegen, Kindalem Dessie & Destaw Damtie. (2021) Candidate Anti-COVID-19 Medicinal Plants from Ethiopia: A Review of Plants Traditionally Used to Treat Viral Diseases. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-20.
Crossref
Crossref
Mustafa EMİRİK. (2021) In Silico Inhibition Potential of Artemisinin Derivatives Against SARS-CoV-2 Main Protease. El-Cezeri Fen ve Mühendislik Dergisi.
Crossref
Crossref
Charlotte Kern, Verena Schöning, Carlos Chaccour & Felix Hammann. (2021) Modeling of SARS-CoV-2 Treatment Effects for Informed Drug Repurposing. Frontiers in Pharmacology 12.
Crossref
Crossref
Suhas G. Kshirsagar & Rammohan V. Rao. (2021) Antiviral and Immunomodulation Effects of Artemisia. Medicina 57:3, pages 217.
Crossref
Crossref
Isabella Romeo, Francesco Mesiti, Antonio Lupia & Stefano Alcaro. (2021) Current Updates on Naturally Occurring Compounds Recognizing SARS-CoV-2 Druggable Targets. Molecules 26:3, pages 632.
Crossref
Crossref
Jing Yang, Yingke He, Yinbao Li, Xing Zhang, Yin-Kwan Wong, Shengnan Shen, Tianyu Zhong, Jianbin Zhang, Qian Liu & Jigang Wang. (2020) Advances in the research on the targets of anti-malaria actions of artemisinin. Pharmacology & Therapeutics 216, pages 107697.
Crossref
Crossref
Yue Zhu & De-Yu Xie. (2020) Docking Characterization and in vitro Inhibitory Activity of Flavan-3-ols and Dimeric Proanthocyanidins Against the Main Protease Activity of SARS-Cov-2. Frontiers in Plant Science 11.
Crossref
Crossref